Does MIRVETUXIMAB SORAVTANSINE-GYNX Cause Carbohydrate antigen 125 increased? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Carbohydrate antigen 125 increased have been filed in association with MIRVETUXIMAB SORAVTANSINE-GYNX. This represents 2.0% of all adverse event reports for MIRVETUXIMAB SORAVTANSINE-GYNX.
22
Reports of Carbohydrate antigen 125 increased with MIRVETUXIMAB SORAVTANSINE-GYNX
2.0%
of all MIRVETUXIMAB SORAVTANSINE-GYNX reports
1
Deaths
1
Hospitalizations
How Dangerous Is Carbohydrate antigen 125 increased From MIRVETUXIMAB SORAVTANSINE-GYNX?
Of the 22 reports, 1 (4.5%) resulted in death, 1 (4.5%) required hospitalization.
Is Carbohydrate antigen 125 increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRVETUXIMAB SORAVTANSINE-GYNX. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does MIRVETUXIMAB SORAVTANSINE-GYNX Cause?
Vision blurred (86)
Neuropathy peripheral (83)
Cataract (68)
Diarrhoea (68)
Pneumonitis (64)
Abdominal pain (62)
Nausea (52)
Death (51)
Dry eye (46)
Keratitis (45)
What Other Drugs Cause Carbohydrate antigen 125 increased?
NIRAPARIB (1,868)
RUCAPARIB CAMSYLATE (562)
OLAPARIB (280)
BEVACIZUMAB (141)
LETROZOLE (61)
CARBOPLATIN (54)
PACLITAXEL (50)
DOXORUBICIN (43)
PEMBROLIZUMAB (36)
COVID-19 VACCINE NOS (27)
Which MIRVETUXIMAB SORAVTANSINE-GYNX Alternatives Have Lower Carbohydrate antigen 125 increased Risk?
MIRVETUXIMAB SORAVTANSINE-GYNX vs MISOPROSTOL
MIRVETUXIMAB SORAVTANSINE-GYNX vs MITAPIVAT
MIRVETUXIMAB SORAVTANSINE-GYNX vs MITOMYCIN
MIRVETUXIMAB SORAVTANSINE-GYNX vs MITOTANE
MIRVETUXIMAB SORAVTANSINE-GYNX vs MITOXANTRONE